ABRETHOR Trademark

Trademark Overview


On Thursday, November 20, 2014, a trademark application was filed for ABRETHOR with the United States Patent and Trademark Office. The USPTO has given the ABRETHOR trademark a serial number of 86460348. The federal status of this trademark filing is CANCELLED - SECTION 8 as of Friday, July 8, 2022. This trademark is owned by Glaxo Group Limited. The ABRETHOR trademark is filed in the Pharmaceutical Products category with the following description:

Pharmaceutical preparations and substances for the treatment of damaged skin and tissue; Pharmaceutical preparations and substances for the treatment of infectious diseases, blood disorders, pain, inflammation, sepsis, alopecia, obesity and cognitive disorders; Pharmaceutical preparations and substances for the treatment of viral, metabolic, endocrine, musculoskeletal, cardiovascular, cardiopulmonary, genitourinary, sexual dysfunction, oncological, hepatological, ophthalmic, respiratory, neurological, gastrointestinal, hormonal, dermatological, psychiatric and immune system related diseases and disorders; Vaccines
abrethor

General Information


Serial Number86460348
Word MarkABRETHOR
Filing DateThursday, November 20, 2014
Status710 - CANCELLED - SECTION 8
Status DateFriday, July 8, 2022
Registration Number4872999
Registration DateTuesday, December 22, 2015
Mark Drawing4000 - Illustration: Drawing with word(s) / letter(s) / number(s) in Block form
Published for Opposition DateTuesday, October 6, 2015

Trademark Statements


Goods and ServicesPharmaceutical preparations and substances for the treatment of damaged skin and tissue; Pharmaceutical preparations and substances for the treatment of infectious diseases, blood disorders, pain, inflammation, sepsis, alopecia, obesity and cognitive disorders; Pharmaceutical preparations and substances for the treatment of viral, metabolic, endocrine, musculoskeletal, cardiovascular, cardiopulmonary, genitourinary, sexual dysfunction, oncological, hepatological, ophthalmic, respiratory, neurological, gastrointestinal, hormonal, dermatological, psychiatric and immune system related diseases and disorders; Vaccines

Classification Information


International Class005 - Pharmaceutical and veterinary preparations; sanitary preparations for medical purposes; dietetic substances adapted for medical use, food for babies; plasters, materials for dressings; material for stopping teeth, dental wax; disinfectants; preparations for destroying vermin; fungicides, herbicides.
US Class Codes006, 018, 044, 046, 051, 052
Class Status Code2 - Sec. 8 - Entire Registration
Class Status DateFriday, July 8, 2022
Primary Code005
First Use Anywhere DateNOT AVAILABLE
First Use In Commerce DateNOT AVAILABLE

Trademark Owner History


Party NameGlaxo Group Limited
Party Type30 - Original Registrant
Legal Entity Type99 - Other
AddressBrentford, Middlesex TW89GS

Party NameGlaxo Group Limited
Party Type20 - Owner at Publication
Legal Entity Type99 - Other
AddressBrentford, Middlesex TW89GS

Party NameGlaxo Group Limited
Party Type10 - Original Applicant
Legal Entity Type99 - Other
AddressBrentford, Middlesex TW89GS

Trademark Events


Event DateEvent Description
Friday, July 8, 2022CANCELLED SEC. 8 (6-YR)
Tuesday, December 22, 2020COURTESY REMINDER - SEC. 8 (6-YR) E-MAILED
Tuesday, February 14, 2017ATTORNEY/DOM.REP.REVOKED AND/OR APPOINTED
Tuesday, February 14, 2017TEAS REVOKE/APP/CHANGE ADDR OF ATTY/DOM REP RECEIVED
Tuesday, December 22, 2015REGISTERED-PRINCIPAL REGISTER
Tuesday, October 6, 2015OFFICIAL GAZETTE PUBLICATION CONFIRMATION E-MAILED
Tuesday, October 6, 2015PUBLISHED FOR OPPOSITION
Wednesday, September 16, 2015NOTIFICATION OF NOTICE OF PUBLICATION E-MAILED
Tuesday, September 1, 2015LAW OFFICE PUBLICATION REVIEW COMPLETED
Monday, August 31, 2015APPROVED FOR PUB - PRINCIPAL REGISTER
Thursday, August 20, 2015TEAS/EMAIL CORRESPONDENCE ENTERED
Thursday, August 20, 2015CORRESPONDENCE RECEIVED IN LAW OFFICE
Wednesday, August 12, 2015ASSIGNED TO LIE
Wednesday, July 29, 2015TEAS RESPONSE TO SUSPENSION INQUIRY RECEIVED
Monday, June 22, 2015TEAS CHANGE OF CORRESPONDENCE RECEIVED
Tuesday, March 3, 2015NOTIFICATION OF LETTER OF SUSPENSION E-MAILED
Tuesday, March 3, 2015LETTER OF SUSPENSION E-MAILED
Tuesday, March 3, 2015SUSPENSION LETTER WRITTEN
Tuesday, March 3, 2015ASSIGNED TO EXAMINER
Saturday, November 29, 2014NEW APPLICATION OFFICE SUPPLIED DATA ENTERED IN TRAM
Monday, November 24, 2014NEW APPLICATION ENTERED IN TRAM